⚠ EXAS is no longer actively traded. Data shown reflects verified historical relationships.
Supply Chain Intelligence

Exact Sciences Corp Supply Chain

EXAS supply chain intelligence for Exact Sciences Corp: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

EXAS ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

6Suppliers
9Customers
3Debt Items
20Related Chains

Exact Sciences Corp Suppliers

TickerNameConfidenceEvidence
U-S-BANK-TRUST-COMPANY-NATIONAL-ASSOCIATION U-S-BANK-TRUST-COMPANY-NATIONAL-ASSOCIATION 90% On March 23, 2026, Exact and U.S. Bank Trust Company, National Association (as successor to U.S. Bank National Association), as trustee (the “ Trustee ”), entered into the Sixth Supplemental Indentur…
FLGT Fulgent Genetics, Inc. 72% Reciprocal relationship from FLGT graph: Reciprocal relationship from EXAS graph: Reciprocal relationship from FLGT graph: supplier of the next generation sequencers and associated reagents we use to…
GH Guardant Health, Inc. 72% Reciprocal relationship from GH graph: biopsy space for therapy selection include Foundation Medicine, Inc., which was acquired by Roche Holdings, Inc. in 2018; Caris Life Sciences, Inc.; Tempus AI, …
NEO NeoGenomics, Inc. 72% Reciprocal relationship from NEO graph: rofitability. The market for genetic and molecular testing services is highly competitive and, given the opportunities in this market within the laboratory tes…
VCYT Veracyte, Inc. 72% Reciprocal relationship from VCYT graph: y requirements, which may be subject to change, and our failure to comply with these requirements could substantially harm our business. Certain of our produc…
VNRX VolitionRx Limited 72% Reciprocal relationship from VNRX graph: ies entering the market. The market for diagnostics is also significantly affected by new product introductions and other market activities of industry partic…

Exact Sciences Corp Customers

TickerNameConfidenceEvidence
USGOV-DEPARTMENT-OF-DEFENSE USGOV-DEPARTMENT-OF-DEFENSE 95% USAspending awards from Department of Defense: $542,223 across 2 awards. W81K0223P0100 ONCOTYPE DX GENOMIC TESTING SERVICES FOR MADIGAN ARMY MEDICAL CENTER, JBLM, WA.; HT001424F0040 ONCOTYPE DX BREAS…
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS 95% USAspending awards from Department of Veterans Affairs: $3,577,350 across 7 awards. 36C10X25F0038 VHA BREAST CANCER MOLECULAR TESTING ORDER 2; 36C25725N0384 ONCOTYPE DX TESTING; 36C24822N0432 ONCOTYP…
ABT Abbott Laboratories 92% Exact entered into an Agreement and Plan of Merger, dated as of November 19, 2025 (the “ Merger Agreement ”), with Abbott Laboratories, an Illinois corporation (“ Abbott ”), and Badger Merger Sub I, …
ABT Abbott Laboratories 92% Reciprocal relationship from ABT graph: Reciprocal relationship from EXAS graph: Reciprocal relationship from ABT graph: Reciprocal relationship from EXAS graph: Exact entered into an Agreement and P…
FLGT Fulgent Genetics, Inc. 72% Reciprocal relationship from FLGT graph: supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole provider of maintenance and repair serv…
GH Guardant Health, Inc. 72% Reciprocal relationship from GH graph: Reciprocal relationship from EXAS graph: Reciprocal relationship from GH graph: Reciprocal relationship from EXAS graph: Reciprocal relationship from GH graph: …
NEO NeoGenomics, Inc. 72% Reciprocal relationship from NEO graph: rofitability. The market for genetic and molecular testing services is highly competitive and, given the opportunities in this market within the laboratory tes…
VCYT Veracyte, Inc. 72% Reciprocal relationship from VCYT graph: Reciprocal relationship from EXAS graph: Reciprocal relationship from VCYT graph: Reciprocal relationship from EXAS graph: Reciprocal relationship from VCYT g…
VNRX VolitionRx Limited 72% Reciprocal relationship from VNRX graph: Reciprocal relationship from EXAS graph: Reciprocal relationship from VNRX graph: ent or clinical trials do not perform as expected, we may not be able to obt…

Exact Sciences Corp Debt Obligations

InstrumentDescriptionConfidenceEvidence
EXAS-DEBT-9409 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
EXAS-DEBT-9408 Xbrl Warrant 90% xbrl warrant detail from xbrl 2013-12-31.
EXAS-DEBT Debt stack $2.5B 90% Market cache reports total debt of $2.5B.

Exact Sciences Corp Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Exact Sciences Corp.

Exact Sciences Corp Ownership

HolderNameConfidenceEvidence
EXAS-OWNER-FARALLON-CAPITAL-MANAGEMENT-LLC FARALLON CAPITAL MANAGEMENT LLC 90% 13F overlay lists FARALLON CAPITAL MANAGEMENT LLC as top holder; 37 tracked holders.

Exact Sciences Corp Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
GIFOF Grifols, S.A. 100.00 2
GRAL GRAIL, Inc. 100.00 1 ['spend']
GH Guardant Health, Inc. 100.00 1 ['customer', 'supplier']
TEM Tempus AI, Inc. 100.00 2
DGX Quest Diagnostics Incorporated 100.00 2
PSNL Personalis, Inc. 100.00 1 ['spend']
BNR Burning Rock Biotech Limited 100.00 2
GIKLY Grifols, S.A. 100.00 2
AORT Artivion, Inc. 100.00 2
ALVO Alvotech 100.00 2
VNRX VolitionRx Limited 100.00 1 ['customer', 'supplier']
CAI Caris Life Sciences, Inc. 100.00 2
ABT Abbott Laboratories 100.00 1 ['customer']
VTAK Catheter Precision, Inc. 100.00 2
CAPR Capricor Therapeutics, Inc. 100.00 2
GRFS Grifols, S.A. 100.00 2
GCTK GlucoTrack, Inc. 100.00 2
FLGT Fulgent Genetics, Inc. 100.00 2 ['customer', 'supplier']
SVA Sinovac Biotech Ltd. 100.00 2
ITGR Integer Holdings Corporation 100.00 2
View EXAS supply chain intel →

Explore the full interactive supply chain map for Exact Sciences Corp.

Open EXAS supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map